SARS-CoV-2 specific immunity in persons with a primary immune deficiency

SARS-CoV-2 immunity in primary immune deficiency

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON24202

Enrollment

Registered

2021-02-16

Start date

2021-02-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Immune Deficiency

Interventions

None

Eligibility

Inclusion criteria

Inclusion criteria: - age 18 or older - diagnosed with primary immune deficiency and a patient at the Leiden University Medical Center - proof of having had COVID-19 by PCR, either by GGD (municipal Health Center) of LUMC

Exclusion criteria

Exclusion criteria: - vaccinated against SARS-CoV-2

Design outcomes

Primary

Measure	Time frame
1. SARS-CoV-2 specific T-cell immunity: CD4+ T cells and CD8+ T cells against SARS-CoV-2 structural proteins (N, M and S) 2. SARS-CoV-2 specific neutralizing antibodies	—

Contacts

Public ContactAnna Roukens

Leiden University Medical Center

a.h.e.roukens@lumc.nl+31715262613

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)